The agreement will see MEDiC’s MCAT platform identify biomarkers to support the development of Hanmi’s clinical assets.

Despite this setback, Transgene plans to explore the potential benefits of the vaccine in specific patient populations.

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief ...

In pharmaceutical manufacturing, viscous drug products pose unique challenges to filling efficiency and accuracy.

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ...

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...

Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare ...

digital twins can be used to progress healthcare, drug development, and research by enabling the delivery of personalised ...

Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract manufactures have a duty to engage with the ...

Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.